Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial: Implementation of Screening and Brief Intervention
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Indian and Alaska Native (AI/AN) serving clinics. The investigators also will assess staff perspectives on this implementation as well as a survey to understand clients at these sites who have chronic pain and opioid misuse/opioid use disorder.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Willing and able to provide informed consent
• have English comprehension and proficiency
• receiving services at one of our participating study sites
• report current chronic pain and/or opioid misuse/opioid use disorder
• self-identify as American Indian/Alaska Native
Locations
United States
California
Clinic Site A (blinded pending tribal approval)
RECRUITING
Arcata
Minnesota
Clinic Site C (blinded pending tribal approval)
NOT_YET_RECRUITING
Minneapolis
Washington
Clinic Site B (blinded pending tribal approval)
NOT_YET_RECRUITING
Toppenish
Contact Information
Primary
Kamilla L Venner, PhD
kamilla@unm.edu
5059252300
Backup
Angel R Vasquez, PhD
vasquez@unm.edu
Time Frame
Start Date: 2023-06-01
Estimated Completion Date: 2028-07
Participants
Target number of participants: 225
Treatments
No_intervention: Pre-Intervention
Baseline prior to any involvement with the project
No_intervention: Intervention
A workgroup for each clinic meets for approximately 6 months to select the specific goals for the clinic to be targeted during the implementation phase.
Active_comparator: Implementation
Evidence-based implementation strategies are put into practice for approximately 6 months.
No_intervention: Sustainment
Measuring the degree to which the clinic maintains the implementation phase goals.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: University of New Mexico